These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7534926)

  • 1. First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1994 Oct; 14(10):963-71. PubMed ID: 7534926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester screening for fetal chromosomal abnormalities. Preliminary results. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1991 Aug; 11(8):621-4. PubMed ID: 1722579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
    Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
    Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
    Hsu JJ; Hseih TT; Liou JD; Soong YK
    J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
    Crossley JA; Aitken DA; Connor JM
    Prenat Diagn; 1993 Apr; 13(4):271-80. PubMed ID: 7685092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum.
    Van Lith JM; Beekhuis JR; Van Loon AJ; Mantingh A; De Wolf BT; Breed AS
    Prenat Diagn; 1991 Aug; 11(8):625-8. PubMed ID: 1722580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome.
    Crandall BF; Golbus MS; Goldberg JD; Matsumoto M
    Prenat Diagn; 1991 Jun; 11(6):377-80. PubMed ID: 1717969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester alpha-fetoprotein screening for Down syndrome.
    Fuhrmann W; Altland K; Jovanovic V; Holzgreve W; Miny P; Wenger D; Rauskolb R
    Prenat Diagn; 1993 Mar; 13(3):215-8. PubMed ID: 7685089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
    Crossley JA; Aitken DA; Connor JM
    Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fetoplacental antigens in pregnancies with fetal chromosomal aberrations].
    Fialová L; Malbohan I; Mikulíková L; Hájek Z
    Sb Lek; 1993; 94(2):179-83. PubMed ID: 7527584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
    Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester alpha-fetoprotein levels in normal and chromosomally abnormal pregnancies.
    Barkai G; Shaki R; Pariente C; Goldman B
    Lancet; 1987 Aug; 2(8555):389. PubMed ID: 2441219
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum CA 125 levels in pregnancies with chromosomally-normal and -abnormal fetuses. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM; Mantingh A; De Bruijn HW
    Prenat Diagn; 1993 Dec; 13(12):1123-31. PubMed ID: 8177831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.